Mutations of


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
28 07 2023
Historique:
received: 19 06 2023
revised: 24 07 2023
accepted: 26 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

It has been shown that the loss of function of the The study included 66 patients with breast cancer. DNA copy number aberrations (CNA) were assessed by high-density CytoScanHD™ Array micro matrix analysis. Gene mutations were assessed by sequencing on the MiSeq™ Sequencing System using the Accel-Amplicon It has been established that the presence of a normal copy number of Currently, there is little data on the effect of chromosomal aberrations and mutations in the BRCA1/2 and PALB2 genes on the effectiveness of treatment and prognosis of the disease. At the same time, the study of these genes has great potential for testing focused on a personalized approach to the treatment of patients with breast cancer.

Identifiants

pubmed: 37628606
pii: genes14081554
doi: 10.3390/genes14081554
pmc: PMC10454606
pii:
doi:

Substances chimiques

BRCA2 protein, human 0
BRCA2 Protein 0
BRCA1 protein, human 0
BRCA1 Protein 0
PALB2 protein, human 0
Fanconi Anemia Complementation Group N Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

FEBS Open Bio. 2017 Dec 13;8(1):56-63
pubmed: 29321957
Wellcome Open Res. 2017 Nov 14;2:110
pubmed: 29387807
Breast Cancer Res Treat. 2009 Feb;113(3):545-51
pubmed: 18302019
Breast Cancer Res. 2015 Aug 19;17:111
pubmed: 26283626
N Engl J Med. 2014 Aug 7;371(6):497-506
pubmed: 25099575
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):7155-60
pubmed: 19369211
Genet Med. 2017 Oct;19(10):1105-1117
pubmed: 28492532
Nat Genet. 1994 Dec;8(4):392-8
pubmed: 7894492
Breast Cancer Res. 2013 Feb 28;15(1):R17
pubmed: 23448497
Ann Oncol. 2019 Apr 1;30(4):558-566
pubmed: 30689707
Ann Surg Oncol. 2021 Jun;28(6):3383-3393
pubmed: 32996020
Am J Hum Genet. 2016 May 5;98(5):801-817
pubmed: 27153395
Mol Cell. 2006 Jun 23;22(6):719-729
pubmed: 16793542
Oncogene. 2019 Mar;38(10):1585-1596
pubmed: 30337689
Nature. 2007 Mar 15;446(7133):316-9
pubmed: 17287723
J Thorac Oncol. 2019 Feb;14(2):304-310
pubmed: 30472259
Int J Mol Sci. 2022 Dec 22;24(1):
pubmed: 36613648
Hered Cancer Clin Pract. 2019 Mar 25;17:11
pubmed: 30962858
Lancet Oncol. 2015 Jun;16(6):638-44
pubmed: 25959805
Clin Genet. 2010 Oct;78(4):373-6
pubmed: 20345474
Breast Cancer Res Treat. 2015 Jun;151(3):629-38
pubmed: 26006067
Int J Cancer. 2020 Oct 15;147(8):2142-2149
pubmed: 32338768
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
BMC Med Genet. 2010 Feb 02;11:20
pubmed: 20122277
Nat Med. 2018 May;24(5):628-637
pubmed: 29713086
Arch Gynecol Obstet. 2013 Oct;288(4):839-44
pubmed: 23553196
Mod Pathol. 2013 Nov;26(11):1461-7
pubmed: 23743929
Comput Biol Chem. 2020 May 20;87:107289
pubmed: 32497983
Breast Cancer Res Treat. 2009 Apr;114(3):457-62
pubmed: 18446436
Best Pract Res Clin Haematol. 2014 Sep-Dec;27(3-4):214-21
pubmed: 25455269
Nat Rev Cancer. 2007 Nov;7(11):861-9
pubmed: 17943134
Hum Mol Genet. 2003 Feb 1;12(3):205-16
pubmed: 12554675
Genet Med. 2018 Dec;20(12):1677-1686
pubmed: 29988077
Cancer Biol Med. 2022 Jan 12;:
pubmed: 35014770
Eur J Breast Health. 2018 Apr 01;14(2):93-99
pubmed: 29774317
BMC Cancer. 2008 May 26;8:146
pubmed: 18501021
Breast Cancer Res. 2007;9(6):R83
pubmed: 18053174
Front Oncol. 2020 Feb 28;10:301
pubmed: 32185139
Breast Cancer Res Treat. 2009 May;115(2):359-63
pubmed: 18649131
Mol Cancer Ther. 2011 Jan;10(1):3-8
pubmed: 21135251
Mol Biol Rep. 2019 Oct;46(5):5537-5541
pubmed: 31273614
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
Front Oncol. 2020 Nov 09;10:592998
pubmed: 33304851
NPJ Breast Cancer. 2020 Jul 24;6:31
pubmed: 32728620
Clin Cancer Res. 2009 May 1;15(9):3214-22
pubmed: 19383810
Nat Rev Cancer. 2016 Feb;16(2):110-20
pubmed: 26775620
JCO Precis Oncol. 2018 Nov;2:1-9
pubmed: 35135099
JAMA Oncol. 2017 Sep 01;3(9):1190-1196
pubmed: 28418444
Nat Rev Genet. 2011 Jan;12(1):32-42
pubmed: 21102527
Vopr Onkol. 2016;62(2):221-6
pubmed: 30452211
Appl Clin Genet. 2013 Jul 19;6:43-52
pubmed: 23935381
Fam Cancer. 2013 Mar;12(1):75-81
pubmed: 23131904
Cancer. 2004 Jun 15;100(12):2512-32
pubmed: 15197792
Fam Cancer. 2013 Dec;12(4):587-95
pubmed: 23471749
Breast Cancer Res Treat. 2012 Feb;132(1):307-15
pubmed: 22052327

Auteurs

Matvey M Tsyganov (MM)

Department of Experimental Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 5, Kooperativny Street, 634050 Tomsk, Russia.
Faculty of Medicine and Biology, Siberian State Medical University, 2, Moskovsky Trakt, 634050 Tomsk, Russia.

Sofia S Sorokovikova (SS)

Department of Experimental Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 5, Kooperativny Street, 634050 Tomsk, Russia.
Biological Institute, National Research Tomsk State University, 36, Lenin Avenue, 634050 Tomsk, Russia.

Elizaveta A Lutzkaya (EA)

Department of Experimental Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 5, Kooperativny Street, 634050 Tomsk, Russia.

Marina K Ibragimova (MK)

Department of Experimental Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 5, Kooperativny Street, 634050 Tomsk, Russia.
Faculty of Medicine and Biology, Siberian State Medical University, 2, Moskovsky Trakt, 634050 Tomsk, Russia.
Biological Institute, National Research Tomsk State University, 36, Lenin Avenue, 634050 Tomsk, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH